# A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

> **NCT06246123** · — · RECRUITING · sponsor: **Eisai Korea Inc.** · enrollment: 2040 (estimated)

## Conditions studied

- Arthritis, Rheumatoid
- Colitis, Ulcerative

## Interventions

- **OTHER:** Non-interventional

## Key facts

- **NCT ID:** NCT06246123
- **Lead sponsor:** Eisai Korea Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-27
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-07-30
- **Target enrollment:** 2040 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06246123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06246123, "A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06246123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*